The Consortium for Neuroscience is offering this grant to promote collaborative and sustainable Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD) neuroscience research in low- and middle-income countries (LMICs). This funding opportunity targets experienced LMIC investigators, encouraging partnerships with US scientists. The grant supports research on diverse dementias, including frontotemporal dementia, Lewy body dementia, vascular cognitive impairment/dementia, and mixed etiology dementias. Its core purpose is to build long-term AD/ADRD neuroscience capacity and research infrastructure in LMICs. Ultimately, this initiative aims to develop effective prevention and mitigation strategies for these conditions, improving public health outcomes in the regions.
Opportunity ID: 356365
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AG-25-032 |
| Funding Opportunity Title: | Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.866 — Aging Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 06, 2024 |
| Last Updated Date: | Sep 06, 2024 |
| Original Closing Date for Applications: | Feb 14, 2025 |
| Current Closing Date for Applications: | Feb 14, 2025 |
| Archive Date: | Mar 22, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $400,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments For profit organizations other than small businesses Independent school districts Private institutions of higher education Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Small businesses City or township governments Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This notice of funding opportunity (NOFO) promotes collaborative research programs to support innovative and sustainable Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD) (including frontotemporal dementia (FTD), Lewy body dementia (LBD), vascular cognitive impairment/dementia (VCID), and mixed etiology dementias (MEDs)) neuroscience research for experienced investigators in low- and middle-income countries (LMICs). These collaborative research programs are expected to contribute to the long-term goals of building sustainable AD/ADRD neuroscience capacity and research, ultimately leading to prevention and mitigation strategies for AD/ADRD in LMICs. This NOFO will support applications submitted from LMIC institutions. LMIC scientists are expected to collaborate with scientists from the United States. Income categories for LMICs are defined by the World Bank athttp://data.worldbank.org/about/country-classifications/country-and-lending-groups. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-032.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 356365 Full Announcement-RFA-AG-25-032 -> RFA-AG-25-032-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00287872 | Oct 07, 2024 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289255 | Nov 27, 2024 | Feb 14, 2025 | View |
Package 1
Mandatory forms
356365 RR_SF424_5_0-5.0.pdf
356365 PHS398_CoverPageSupplement_5_0-5.0.pdf
356365 RR_OtherProjectInfo_1_4-1.4.pdf
356365 PerformanceSite_4_0-4.0.pdf
356365 RR_KeyPersonExpanded_4_0-4.0.pdf
356365 PHS398_ResearchPlan_5_0-5.0.pdf
356365 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356365 RR_Budget_3_0-3.0.pdf
356365 RR_SubawardBudget30_3_0-3.0.pdf
356365 PHS398_ModularBudget_1_2-1.2.pdf
356365 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
356365 RR_SF424_5_0-5.0.pdf
356365 PHS398_CoverPageSupplement_5_0-5.0.pdf
356365 RR_OtherProjectInfo_1_4-1.4.pdf
356365 PerformanceSite_4_0-4.0.pdf
356365 RR_KeyPersonExpanded_4_0-4.0.pdf
356365 PHS398_ResearchPlan_5_0-5.0.pdf
356365 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356365 RR_Budget_3_0-3.0.pdf
356365 RR_SubawardBudget30_3_0-3.0.pdf
356365 PHS398_ModularBudget_1_2-1.2.pdf
356365 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
